Large unsatisfied patient populations are at epidemic levels.
20 million adults suffer each year with depression...
$19.4 billion spent annually on various therapies.
Less than half of patients respond to SSRI drug treatments and are now dependent upon them.
Many are left seeking alternative therapies to treat their depression. Until now alternative choices have been limited to electroconvulsive therapy (ECT) and repetitive trans cranial magnetic stimulation (TMS). These are insufficient for many patients and require a significant investment or hospitalization.
Name a therapy that is 80% effective and is not known to 98% of this population who suffer from depression, PTSD and anxiety disorders?
The answer....IV Ketamine therapy....fact not fiction.